Leucotropin: Filed for Canadian approval of a Phase II/III trial

Cangene Corp. (TSE:CNJ) Product: Leucotropin, granulocyte macrophage colony stimulating factor Indication: AIDS patients with low white blood cell counts Status: Filed for Canadian approval of a Phas...